Isomorphic Labs, the drug discovery start-up led by Sir Demis Hassabis, has accelerated spending on staff and research, as the new Nobel Prize winner expands an ambitious push to “solve” diseases.
由德米斯•哈萨比斯(Demis Hassabis)爵士领导的药物发现初创公司同构实验室(Isomorphic Labs)加快了对员工和研究的支出，因为这位新的诺贝尔奖得主正在扩大其雄心勃勃的“解决”疾病的努力。
您已阅读8%（301字），剩余92%（3318字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。